R J Reynolds Tobacco Company (Sr 6/2020/PT/KOL) v. The Controller General Of Patents Designs and Trademarks And Anr

In the world of intellectual property, decisions must be grounded in evidence, not assumptions. But what happens when a patent examiner rejects an application based purely on a generalized belief about a product's harm, without citing any scientific data or reasoned analysis? This case involving R J Reynolds Tobacco Company lays bare the danger of letting preconceived notions replace rigorous examination, and serves as a critical reminder to founders and IP professionals that even the most well-known public health concerns cannot substitute for substantive legal reasoning.

R J Reynolds Tobacco Company, a major player in the tobacco industry, filed a patent application directed at a method related to a tobacco flavorant. The application was examined by the Assistant Controller of Patents, who ultimately refused to grant the patent. The sole basis for this refusal was the invocation of Section 3(b) of the Patents Act, a provision that excludes inventions whose exploitation would be contrary to public order or morality, or which cause serious prejudice to human health. The petitioner found itself staring at a rejection that, in its view, was built on nothing more than a sweeping assumption that all forms of tobacco are inherently injurious to human health.

R J Reynolds Tobacco Company pushed back hard against the rejection, arguing that the Assistant Controller's order was fundamentally flawed. The petitioner contended that the refusal was based merely on a preconceived notion about tobacco, rather than any concrete scientific basis or reasoned evaluation of the specific invention in question. In essence, the company argued that the examiner had substituted personal or generalized assumptions for the kind of evidence-based analysis that the patent examination process demands. The Controller General of Patents, on the other hand, stood by the rejection, with the underlying logic being that any invention tied to tobacco necessarily falls foul of public health considerations under Section 3(b).

The Calcutta High Court sided with the petitioner. The court found the Assistant Controller's order to be unsubstantiated and arbitrary, ruling that the application of Section 3(b) cannot rest on generalized or subjective notions about public health prejudice. Instead, any refusal under this provision must be supported by reasoned findings and scientific evidence. The court set aside the impugned order and remanded the matter back for fresh consideration, signaling that the patent office must do more than simply invoke a provision; it must justify its application with substance.

For founders, inventors, and IP professionals, this case delivers a clear and actionable lesson: the rejection of a patent application on public health or morality grounds must be backed by reasoned findings and scientific evidence, not blanket assumptions. If you are working in a controversial or heavily scrutinized industry, do not assume that an examiner's generalized views will hold up under judicial scrutiny. Push back when a refusal lacks substantive justification, and remember that the burden of reasoned decision-making lies with the patent authority, not with the applicant.